Off-label intravitreal eculizumab for geographic atrophy: report of the first two cases
Abstract Purpose To report the feasibility and short-term safety of off-label intravitreal eculizumab as a complement-inhibition strategy for geographic atrophy (GA) secondary to age-related macular degeneration (AMD), based on two clinical cases. Case reports Two pseudophakic patients with progress...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2026-04-01
|
| Edice: | International Journal of Retina and Vitreous |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s40942-026-00842-1 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|